{
    "nctId": "NCT00401245",
    "officialTitle": "The Effect of Dose Titration and Dose Tapering on the Tolerability of DVS SR in Women With Vasomotor Symptoms Associated With Menopause: The PRIMMUS (PRIstiq for Managing Menopause and Understanding Symptoms) Study",
    "inclusionCriteria": "* Generally healthy, postmenopausal woman who seeks treatment for hot flushes.\n* Meets 1 of the following: At least 12 months of spontaneous amenorrhea; At least 6 months of spontaneous amenorrhea with serum follicle-stimulating hormone (FSH) levels \\> 40 mIU/mL; At least 6 weeks postsurgical bilateral oophorectomy (with or without hysterectomy). Hysterectomized without bilateral oophorectomy and with serum FSH levels \\>40 mIU/mL.\n* Must be FEMALE\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* History of a seizure disorder other than a single childhood febrile seizure.\n* History or presence of clinically important hepatic or renal disease or other medical disease.\n* Presence or recent history of major depressive disorder, bipolar disorder, psychotic disorder, or generalized anxiety disorder requiring therapy."
}